NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Liminal BioSciences Inc (TO: LMNL)

 
LMNL Technical Analysis
5
As on 15th Dec 2021 LMNL STOCK Price closed @ 0.95 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.50 & Strong Sell for SHORT-TERM with Stoploss of 5.50 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

LMNLSTOCK Price

Open 0.92 Change Price %
High 0.98 1 Day 0.03 3.26
Low 0.92 1 Week -0.33 -25.78
Close 0.95 1 Month -1.05 -52.50
Volume 198970 1 Year -10.07 -91.38
52 Week High 11.02 | 52 Week Low 0.92
 
TO Canada Most Active Stocks
YRI 7.89 0.13%
CNQ 75.27 0.40%
UEX 0.50 16.28%
SU 40.43 0.02%
SJR-B 40.48 0.02%
OREA 0.02 -77.78%
VFF 8.12 0.87%
ENB 50.62 -0.80%
TD 79.12 0.16%
AC 22.37 0.22%
 
TO Canada Top Gainers Stocks
AAB 0.05 25.00%
AAB 0.05 25.00%
HLS 5.88 24.31%
HLS 5.88 24.31%
HLS 5.88 24.31%
HLS 5.88 24.31%
HLS 5.88 24.31%
HLS 5.88 24.31%
UEX 0.50 16.28%
WM 0.16 14.29%
 
TO Canada Top Losers Stocks
OREA 0.02 -77.78%
OREA 0.02 -77.78%
NCF 0.02 -33.33%
GLG 0.05 -16.67%
GLG 0.05 -16.67%
CWEB-WR 0.10 -16.67%
GTMS 0.97 -15.65%
TMD 0.18 -14.29%
TMD 0.18 -14.29%
TMD 0.18 -14.29%
 
 
LMNL
Daily Charts
LMNL
Intraday Charts
Whats New @
Bazaartrend
LMNL
Free Analysis
 
LMNL Important Levels Intraday
RESISTANCE1.07
RESISTANCE1.03
RESISTANCE1.01
RESISTANCE0.98
SUPPORT0.92
SUPPORT0.89
SUPPORT0.87
SUPPORT0.83
 
LMNL Forecast May 2024
4th UP Forecast6.77
3rd UP Forecast4.9
2nd UP Forecast3.75
1st UP Forecast2.6
1st DOWN Forecast-0.7
2nd DOWN Forecast-1.85
3rd DOWN Forecast-3
4th DOWN Forecast-4.87
 
LMNL Weekly Forecast
4th UP Forecast7.10
3rd UP Forecast5.13
2nd UP Forecast3.91
1st UP Forecast2.69
1st DOWN Forecast-0.79
2nd DOWN Forecast-2.01
3rd DOWN Forecast-3.23
4th DOWN Forecast-5.20
 
LMNL Forecast2024
4th UP Forecast22.36
3rd UP Forecast15.49
2nd UP Forecast11.25
1st UP Forecast7
1st DOWN Forecast-5.1
2nd DOWN Forecast-9.35
3rd DOWN Forecast-13.59
4th DOWN Forecast-20.46
 
 
LMNL Other Details
Segment EQ
Market Capital 539542464.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
LMNL Address
LMNL
 
LMNL Latest News
 
Your Comments and Response on Liminal BioSciences Inc
 
LMNL Business Profile
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel treatments for patients suffering from diseases that have unmet medical needs. It operates through two segments, Small Molecule Therapeutics and Plasma Derived Therapeutics. The Small Molecule Therapeutics segment's lead product candidate is fezagepras (PBI-4050) for the treatment of idiopathic pulmonary fibrosis, respiratory diseases, and Alström Syndrome. The Plasma Derived Therapeutics segment provides Plasma Protein Purification System, a multi-product sequential purification process for the extraction and purification of therapeutic proteins from human plasma. It also engages in developing Ryplazim for the treatment of congenital plasminogen deficiency. The company operates in Canada, the United Kingdom, and the United States. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada. Address: 440 Armand-Frappier Boulevard, Laval, QC, Canada, H7V 4B4
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service